Finally, TβR1 contain a single cytoplasmic binding site for Cluster of differentiation 44 (CD44) [40], suggesting a potential interaction between the TGFβ pathway and CD44, a cancer-associated glycoprotein previously reported as an OPN receptor [41]. Here, CD44 is linked to cancer.